Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2021 17:12 ET | Source: Adagio Therapeutics, Inc.

アダジオ･セラピューティクス、新型コロナウイルス感染症予防薬ADG20の第2/3相臨床試験で世界的に患者集団の拡張を発表

マサチューセッツ州ウォルサム発, Sept. 11, 2021 (GLOBE NEWSWIRE) -- パンデミックの可能性がある感染症用に抗体ベースのソリューションの創薬、開発、販売を主な事業とする臨床用バイオ医薬品企業であるアダジオ･セラピューティクス (Adagio Therapeutics)...
September 10, 2021 17:12 ET | Source: Adagio Therapeutics, Inc.

Adagio Therapeutics 宣佈在全球第 2/3 期 ADG20 預防 2019 冠狀病毒病臨床試驗中擴大患者人口

麻省沃爾瑟姆, Sept. 11, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. 是一家臨床階段生物製藥公司，專門發現、開發及商業化具有疫情潛力的傳染病抗體解決方案，今天宣佈關於使用 ADG20 預防 2019 冠狀病毒病的 EVADE 第 2/3 期試驗的獨立數據監測委員會 (IDMC) 剛提出一項建議，將擴大第 3...
September 10, 2021 06:30 ET | Source: Adagio Therapeutics, Inc.

Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based...
September 01, 2021 06:30 ET | Source: Adagio Therapeutics, Inc.

Adagio Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

WALTHAM, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...
August 10, 2021 16:22 ET | Source: Adagio Therapeutics, Inc.

Adagio Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based...